血管イメージングデバイスの世界市場：洞察、競合情勢、市場予測：2030年

世界の血管イメージングデバイスの市場規模は、2023年に81億2,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に5.45％のCAGRで拡大し、2030年には111億2,000万米ドルに達すると予測されています。血管イメージングデバイスの需要は、主に高血圧、不整脈、糖尿病などの血管関連疾患に罹患している膨大な数の患者の蔓延によって動機づけられています。さらに、血管イメージングデバイスは、パンデミック状況におけるCOVID-19症例において非常に有益であることが判明し、これらのデバイスの需要をさらに押し上げました。さらに、技術の進歩や適切な手術計画や長期的な疾患管理のためのこれらの機器の要件は、最終的に市場の成長を後押しします。血管イメージングは通常、非侵襲的な手順であるという事実も、市場の成長をエスカレートさせています。

血管イメージングデバイスは、血管組織を観察することによって血管関連疾患を診断するために使用されます。糖尿病や高血圧の有病率の上昇が血管イメージングデバイス市場の成長を牽引しています。また、技術の進歩により、装置は非侵襲的であり、血管解剖学的構造を特定するために複数の放射線科医によって使用されています。

COVID-19の発生により、ほぼすべての国が影響を受けました。現在、多くの国がヘルスケアシステムの改善に乗り出しています。そのため、予防措置として世界中の政府が新しい病院や診断センターを建設し始め、そこでは血管イメージングが最優先されています。そのため、超音波やCT、MRIなどの血管イメージングデバイスが必要となります。

当レポートでは、世界の血管イメージングデバイス市場について調査し、市場の概要とともに、タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 血管イメージングデバイス市場レポートのイントロダクション

第2章 血管イメージングデバイス市場のエグゼクティブサマリー

第3章 規制と特許の分析

• 米国
• 欧州
• 日本

第4章 血管イメージングデバイス市場の主な要因分析

• 血管イメージングデバイス市場の促進要因
• 血管イメージングデバイス市場の抑制要因と課題
• 血管イメージングデバイス市場の機会

第5章 血管イメージングデバイスにおけるポーターのファイブフォース分析

第6章 血管イメージングデバイス市場に対するCOVID-19の影響分析

第7章 血管イメージングデバイス市場の概要

• タイプ別
• 用途別
• エンドユーザー別
• 地域別

第8章 血管イメージングデバイスの世界企業シェア分析-主要3～5社

第9章 血管イメージングデバイスの企業と製品プロファイル

• Siemens Healthcare Limited
• General Electric Company (GE Healthcare)
• Koninklijke Philips N.V.
• FUJIFILM Healthcare
• Samsung Medison Co., Ltd.
• Shimadzu Corporation
• Hologic, Inc.
• Abbott Laboratories
• Carestream Health Inc.
• Toshiba Medical Systems Corporation
• Terumo Corporation
• ESAOTE SPA
• Konica Minolta, Inc.
• Alpinion Medical Systems Co., Ltd.
• Pie Medical Imaging B.V

第10章 プロジェクトのアプローチ

第11章 KOLのビュー

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

List of Tables

• Table 1 Competitive Analysis
• Table 2 COVID-19 Impact Analysis
• Table 3 Vascular Imaging Devices in Global (2021-2030)
• Table 4 Vascular Imaging Devices in Global by Type (2021-2030)
• Table 5 Vascular Imaging Devices in Global by Application (2021-2030)
• Table 6 Vascular Imaging Devices in Global by End User (2021-2030)
• Table 7 Vascular Imaging Devices in Global by Geography (2021-2030)
• Table 8 Vascular Imaging Devices in North America (2021-2030)
• Table 9 Vascular Imaging Devices in North America by Type (2021-2030)
• Table 10 Vascular Imaging Devices in North America by Application (2021-2030)
• Table 11 Vascular Imaging Devices in North America by End User (2021-2030)
• Table 12 Vascular Imaging Devices in North America by Country (2021-2030)
• Table 13 Vascular Imaging Devices in the US (2021-2030)
• Table 14 Vascular Imaging Devices in Canada (2021-2030)
• Table 15 Vascular Imaging Devices in Mexico (2021-2030)
• Table 16 Vascular Imaging Devices in Europe (2021-2030)
• Table 17 Vascular Imaging Devices in Europe by Type (2021-2030)
• Table 18 Vascular Imaging Devices in Europe by Application (2021-2030)
• Table 19 Vascular Imaging Devices in Europe by End User (2021-2030)
• Table 20 Vascular Imaging Devices in Europe by Country (2021-2030)
• Table 21 Vascular Imaging Devices in France (2021-2030)
• Table 22 Vascular Imaging Devices in Germany (2021-2030)
• Table 23 Vascular Imaging Devices in UK (2021-2030)
• Table 24 Vascular Imaging Devices in Italy (2021-2030)
• Table 25 Vascular Imaging Devices in Spain (2021-2030)
• Table 26 Vascular Imaging Devices in Russia (2021-2030)
• Table 27 Vascular Imaging Devices in Rest of Europe (2021-2030)
• Table 28 Vascular Imaging Devices in Asia Pacific (2021-2030)
• Table 29 Vascular Imaging Devices in Asia Pacific by Type (2021-2030)
• Table 30 Vascular Imaging Devices in Asia Pacific by Application (2021-2030)
• Table 31 Vascular Imaging Devices in Asia Pacific by End User (2021-2030)
• Table 32 Vascular Imaging Devices in Asia Pacific by Country (2021-2030)
• Table 33 Vascular Imaging Devices in China (2021-2030)
• Table 34 Vascular Imaging Devices in Japan (2021-2030)
• Table 35 Vascular Imaging Devices in India (2021-2030)
• Table 36 Vascular Imaging Devices in Australia (2021-2030)
• Table 37 Vascular Imaging Devices in South Korea (2021-2030)
• Table 38 Vascular Imaging Devices in Rest of Asia Pacific (2021-2030)
• Table 39 Vascular Imaging Devices in Rest of the World (2021-2030)
• Table 40 Vascular Imaging Devices in Rest of the World by Type (2021-2030)
• Table 41 Vascular Imaging Devices in Rest of the World by Application (2021-2030)
• Table 42 Vascular Imaging Devices in Rest of the World by End User (2021-2030)
• Table 43 Vascular Imaging Devices in Rest of the World by Country (2021-2030)
• Table 44 Vascular Imaging Devices in Middle East (2021-2030)
• Table 45 Vascular Imaging Devices in Africa (2021-2030)
• Table 46 Vascular Imaging Devices in South America (2021-2030)

List of Figures

• Figure 1 Competitive Analysis
• Figure 2 COVID-19 Impact Analysis
• Figure 3 Vascular Imaging Devices in Global (2021-2030)
• Figure 4 Vascular Imaging Devices in Global by Type (2021-2030)
• Figure 5 Vascular Imaging Devices in Global by Application (2021-2030)
• Figure 6 Vascular Imaging Devices in Global by End User (2021-2030)
• Figure 7 Vascular Imaging Devices in Global by Geography (2021-2030)
• Figure 8 Vascular Imaging Devices in North America (2021-2030)
• Figure 9 Vascular Imaging Devices in North America by Type (2021-2030)
• Figure 10 Vascular Imaging Devices in North America by Application (2021-2030)
• Figure 11 Vascular Imaging Devices in North America by End User (2021-2030)
• Figure 12 Vascular Imaging Devices in North America by Country (2021-2030)
• Figure 13 Vascular Imaging Devices in the US (2021-2030)
• Figure 14 Vascular Imaging Devices in Canada (2021-2030)
• Figure 15 Vascular Imaging Devices in Mexico (2021-2030)
• Figure 16 Vascular Imaging Devices in Europe (2021-2030)
• Figure 17 Vascular Imaging Devices in Europe by Type (2021-2030)
• Figure 18 Vascular Imaging Devices in Europe by Application (2021-2030)
• Figure 19 Vascular Imaging Devices in Europe by End User (2021-2030)
• Figure 20 Vascular Imaging Devices in Europe by Country (2021-2030)
• Figure 21 Vascular Imaging Devices in France (2021-2030)
• Figure 22 Vascular Imaging Devices in Germany (2021-2030)
• Figure 23 Vascular Imaging Devices in UK (2021-2030)
• Figure 24 Vascular Imaging Devices in Italy (2021-2030)
• Figure 25 Vascular Imaging Devices in Spain (2021-2030)
• Figure 26 Vascular Imaging Devices in Russia (2021-2030)
• Figure 27 Vascular Imaging Devices in Rest of Europe (2021-2030)
• Figure 28 Vascular Imaging Devices in Asia Pacific (2021-2030)
• Figure 29 Vascular Imaging Devices in Asia Pacific by Type (2021-2030)
• Figure 30 Vascular Imaging Devices in Asia Pacific by Application (2021-2030)
• Figure 31 Vascular Imaging Devices in Asia Pacific by End User (2021-2030)
• Figure 32 Vascular Imaging Devices in Asia Pacific by Country (2021-2030)
• Figure 33 Vascular Imaging Devices in China (2021-2030)
• Figure 34 Vascular Imaging Devices in Japan (2021-2030)
• Figure 35 Vascular Imaging Devices in India (2021-2030)
• Figure 36 Vascular Imaging Devices in Australia (2021-2030)
• Figure 37 Vascular Imaging Devices in South Korea (2021-2030)
• Figure 38 Vascular Imaging Devices in Rest of Asia Pacific (2021-2030)
• Figure 39 Vascular Imaging Devices in Rest of the World (2021-2030)
• Figure 40 Vascular Imaging Devices in Rest of the World by Type (2021-2030)
• Figure 41 Vascular Imaging Devices in Rest of the World by Application (2021-2030)
• Figure 42 Vascular Imaging Devices in Rest of the World by End User (2021-2030)
• Figure 43 Vascular Imaging Devices in Rest of the World by Country (2021-2030)
• Figure 44 Vascular Imaging Devices in Middle East (2021-2030)
• Figure 45 Vascular Imaging Devices in Africa (2021-2030)
• Figure 46 Vascular Imaging Devices in South America (2021-2030)
• Figure 47 Market Drivers
• Figure 48 Market Barriers
• Figure 49 Market Opportunities
• Figure 50 PORTER'S Five Force Analysis

Vascular Imaging Devices Market By Type (Minimally Invasive [Catheter Angiogram, CT Angiography [CTA], Lymphoscintigraphy, Venogram, Intravascular Ultrasound], Non-Invasive [Abdominal Ultrasound, Angiography, Ankle-Brachial Index [ABI], Captopril Renal Scan, Magnetic Resonance Angiography [MRA], Magnetic Resonance Imaging [MRI], Carotid Duplex Ultrasound, CT Scan, Doppler Ultrasound, Duplex Ultrasound), By Application (Diagnostics and Therapeutics), By End-User (Hospitals, Diagnostic Imaging Centers, Others), By Geography is expected to grow at a steady CAGR Forecast till 2030 owing to rising technological advancement and increasing prevalence of Vascular-Related Diseases

Global Vascular Imaging Devices Market was valued at USD 8.12 billion in 2023, growing at a CAGR of 5.45% during the forecast period from 2024 to 2030, to reach USD 11.12 billion by 2030. The demand for Vascular Imaging Devices is primarily motivated by the prevalence of a vast number of patients suffering from vascular-related diseases like hypertension, arrhythmias, and diabetes, additionally, vascular imaging devices were found to be extremely beneficial in COVID-19 cases in the pandemic situation which further pushed for the demand of these devices. Moreover, technological advancements and requirements of these devices for proper surgical planning and long-term disease management will eventually boost the market growth. The fact that Vascular Imaging is usually a non-invasive procedure is also escalating the growth of the market.

Vascular Imaging Devices Market Dynamics:

Vascular Imaging Devices are used in diagnosing vascular-related diseases by viewing vascular tissues. The increasing prevalence of diabetes and hypertension are responsible to drive the growth of the Vascular Imaging Devices market. Also, due to the technological advancements the devices are non-invasive and are used by several radiologists to identify vascular anatomy.

Based on data from NHANES (National Health and Nutrition Examination Survey; 2013-2016), an estimated 26 million adults have been diagnosed with diabetes, 9.4 million adults (3.7%) have undiagnosed diabetes, and 91.8 million adults (37.6%) have prediabetes.

As per American Heart Association, 2022, the incidence of end-stage kidney disease in the United States is projected to increase 11% to 18% through 2030. This will eventually lead to more prevalence of renal diseases and it will further boost the Global Vascular Imaging Devices market growth.

With the outbreak of COVID-19, almost all the countries were affected. Currently, numerous countries have started to improve their healthcare systems. Hence, as a preventive measure, governments across the world have started building new hospitals and diagnostic centers, where vascular imaging is kept as utmost priority. Henceforth, it requires vascular imaging devices, such as Ultrasound and CT, MRI machines.

Screening at home is critical in stopping the virulent spread of the virus. According to a paper published by the Chinese Center for Disease Control and Prevention, in February 2020, only 19% of patients who contracted COVID-19 had conditions severe enough to require hospitalization. The effect on the other 81% was mild enough for them to recover safely at home. This 19% will require the use of ultrasound imaging of both their lungs, which will substantially promote the market for vascular imaging devices. Thus, all these factors are projected to drive the growth of the market for Vascular Imaging Devices.

Certain factors such as the very high cost of the equipment and the requirement of skilled and trained professionals for operating pose a major hurdle for the growth of the Vascular Imaging Devices market

Vascular Imaging Devices Market Segment Analysis:

Vascular Imaging Devices by Type (Minimally Invasive [Catheter Angiogram, CT Angiography [CTA], Lymphoscintigraphy, Venogram, Intravascular Ultrasound], Non-Invasive [Abdominal Ultrasound, Angiography, Ankle-Brachial Index [ABI], Captopril Renal Scan, Magnetic Resonance Angiography [MRA], Magnetic Resonance Imaging [MRI], Carotid Duplex Ultrasound, CT Scan, Doppler Ultrasound, Duplex Ultrasound), Vascular Imaging Devices market by Application (Diagnostics And Therapeutics), Vascular Imaging Devices market by End User (Hospitals, Diagnostic Imaging Centers, Others), and Vascular Imaging Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Vascular Imaging Devices market type segment, non-invasive devices are expected to hold the largest share in the market as it is an important tool in the clinical assessment of patients, with a variety of vascular-related conditions. It allows the detection of changes in blood flow and rhythm, and it is essential in the detection of life-threatening arrhythmias. There are various types of non-invasive devices available in the Vascular Imaging Devices market, such as Abdominal Ultrasound, Angiography, Captopril Renal Scan, MRA, MRI, Carotid Duplex Ultrasound, CT Scan, Doppler Ultrasound, Duplex Ultrasound, among others.

The Vascular Imaging Devices market is driven by the factors such as the increase in the prevalence of heart disease, like stroke, and a growing aging population who are very susceptible to coronary heart disease, technological developments in vascular imaging devices that minimize the chances of further infection, and improved efficiency of devices. In August 2022, The US Food and Drug Administration (FDA) has cleared Abbott's latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software. It combines OCT with artificial intelligence (AI) to provide physicians an enhanced, comprehensive view of coronary blood flow and blockages to assist physician decision-making in the cath lab and provide the best pathway for treatment.

Additionally, assistance from government bodies, in equipping new/existing hospitals and healthcare centers in rural regions, is expected to enhance the market potential in several countries. Hence, all the above-mentioned factors are expected to drive the segment growth.

North America is expected to dominate the overall Vascular Imaging Devices Market:

North America is expected to dominate the overall Vascular Imaging Devices market during the forecast period. This domination is due to the growing demand for advanced technologies in these devices, the increasing vascular diseases in the region are driving the regional growth. Additionally, high capital expenditure like building super-specialty Hospitals and Surgical centers is expected to boost the Global Vascular Imaging Devices market growth.

Further, In the United States, according to the Centers for Disease Control and Prevention (CDC), in 2020, approximately 6.5 million people age 40 and older have PAD, which in turn, will increase the demand for Vascular Imaging devices. This situation is giving rise to a critical need for Vascular Imaging devices for the diagnosis, prevention, and treatment of the disease.

Europe and Asia-Pacific region have the future potential growth for the Global Vascular Imaging Devices. This is due to the fact that many key players are now available in these regions. In all countries, vascular-related illness rates have been increasing. Several reports have been released annually, mentioning that significant portions of the population in the European Union and the United States (including in the developed market) suffer through more than one chronic disorder, such as hypertension, arrhythmias, diabetes, for a prolonged period, thus there is an enormous potential for Vascular Imaging Devices market growth.

Vascular Imaging Devices Market Key Players:

Some of the key market players operating in the Vascular Imaging Devices market include Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Samsung Medison, Shimadzu Corporation, St. Jude Medical, Inc., TERUMO Corporation, Koninklijke Philips N.V., Hologic, Inc., Esaote SpA, Carestream Health, Inc. and others.

Recent Developmental Activities in The Vascular Imaging Devices Market:

In August 2022, Abbott Laboratories received the US Food and Drug Administration (FDA) go-ahead for its latest optical coherence tomography (OCT) imaging platform, powered by the company's new Ultreon Software. The Ultreon Software is first-of-its-kind imaging software that combines OCT with artificial intelligence (AI). The United States' clearance for the OCT imaging platform closely follows the attainment of CE Mark for the same in Europe.

In August 2022, Pulse Medical Imaging Technology (Shanghai) Co. Ltd. has raised more than USD 100 million in a Series C funding round to accelerate the R&D, clinical trials, and commercialization of its products. Pulse plans to use the funds to accelerate the commercialization of its fractional flow reserve (FFR) estimating systems. FFR is a method to measure blood pressure and flow within a coronary artery to check on the possibility that the stenosis impedes oxygen delivery to the heart muscle.

In August 2022, Trivitron has recently launched SonoRad V60 Ultrasound, devoted to delivering excellent imaging systems and exceptional image quality.

Key Takes Away from the Vascular Imaging Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Vascular Imaging Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Vascular Imaging Devices Market.

Various opportunities are available for the other competitor in the Vascular Imaging Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Vascular Imaging Devices market growth in the coming future?

Target Audience who can be benefited from this Vascular Imaging Devices Market Ket Report Study

Vascular Imaging Devices providers

Research organizations and consulting companies

Vascular Imaging Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Vascular Imaging Devices

Various End-users want to know more about the Vascular Imaging Devices Market and the latest technological developments in the Vascular Imaging Devices market.

Frequently Asked Questions for Vascular Imaging Devices Market:

What are Vascular Imaging Devices?

Vascular imaging devices are used in diagnosing vascular-related diseases by viewing vascular tissues. The increasing prevalence of diabetes and hypertension are responsible to drive the growth of the market. Also, due to the technological advancements the devices are non-invasive and are used by several radiologists to identify vascular anatomy.

What is the market for Global Vascular Imaging Devices?

Global Vascular Imaging Devices Market was valued at USD 8.12 billion in 2023, growing at a CAGR of 5.45% during the forecast period from 2024 to 2030, to reach USD 11.12 billion by 2030.

What are the drivers for Global Vascular Imaging Devices?

The major drivers driving the demand for Vascular Imaging Devices are the prevalence of a vast number of patients suffering from vascular-related diseases like hypertension, arrhythmias, and diabetes, additionally, vascular imaging devices were found to be extremely beneficial in COVID-19 cases in the pandemic situation.

What are the key players operating in Global Vascular Imaging Devices?

Some of the key market players operating in the Vascular Imaging Devices market include Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Samsung Medison, Shimadzu Corporation, St. Jude Medical, Inc., TERUMO Corporation, Koninklijke Philips N.V., Hologic, Inc., Esaote SpA, Carestream Health, Inc. and others.

What regions have the highest share in the Vascular Imaging Devices market?

North America is expected to dominate the overall Vascular Imaging Devices market during the forecast period, 2024 to 2030. This domination is due to the growing demand for advanced technologies in these devices, the increasing vascular diseases in the region are driving the regional growth. Additionally, high capital expenditure like building super-specialty Hospitals and Surgical centers is expected to boost the market growth.

Table of Contents

1. Vascular Imaging Devices Market Report Introduction

2. Vascular Imaging Devices Market Executive summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment
• 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1 The United States
• 3.2 Europe
  • 3.2.1 Germany
  • 3.2.2 France
  • 3.2.3 Italy
  • 3.2.4 Spain
  • 3.2.5 U.K.
• 3.3 Japan

4. Vascular Imaging Devices Market Key factors analysis

• 4.1 Vascular Imaging Devices Market Drivers
  • 4.1.1 Growing prevalence of vascular-related diseases in the rising geriatric population
  • 4.1.2 Outbreak of the Covid-19 pandemic
  • 4.1.3 Technological advancements in product development
  • 4.1.4 Increasing adoption rates of minimally invasive surgeries
• 4.2 Vascular Imaging Devices Market Restraints and Challenges
  • 4.2.1 High cost of equipment
  • 4.2.2 Unavailability of skilled and trained professionals
• 4.3 Vascular Imaging Devices Market Opportunities
  • 4.3.1 Increasing health awareness in emerging countries
  • 4.3.2 Growing demand for vascular imaging devices in multispeciality and diagnostic care settings

5. Vascular Imaging Devices Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Vascular Imaging Devices Market

7. Vascular Imaging Devices Market layout

• 7.1 By Type
  • 7.1.1 Minimally Invasive
    • 7.1.1.1 Catheter Angiogram
    • 7.1.1.2 CT Angiography (CTA)
    • 7.1.1.3 Lymphoscintigraphy
    • 7.1.1.4 Venogram
    • 7.1.1.5 Intravascular Ultrasound
  • 7.1.2 Non-Invasive
    • 7.1.2.1 Abdominal Ultrasound
    • 7.1.2.2 Angiography
    • 7.1.2.3 Ankle-Brachial Index (ABI)
    • 7.1.2.4 Captopril Renal Scan
    • 7.1.2.5 Carotid Duplex Ultrasound
    • 7.1.2.6 CT Scan
    • 7.1.2.7 Doppler Ultrasound
    • 7.1.2.8 Duplex Ultrasound
    • 7.1.2.9 Magnetic Resonance Angiography (MRA)
    • 7.1.2.10 Magnetic Resonance Imaging (MRI)
• 7.2 By Application
  • 7.2.1 Diagnostics
  • 7.2.2 Therapeutics
• 7.3 By End-user
  • 7.3.1 Hospitals
  • 7.3.2 Diagnostic Imaging Centers
  • 7.3.3 Others
• 7.4 By Geography
  • 7.4.1 North America
    • 7.4.1.1 North America Interventional Cardiology Devices Market, by Type
    • 7.4.1.2 North America Interventional Cardiology Devices Market, by Application
    • 7.4.1.3 North America Interventional Cardiology Devices Market, by End-user
    • 7.4.1.4 North America Interventional Cardiology Devices Market, by Country
    • 7.4.1.4.1 United States
    • 7.4.1.4.2 Canada
    • 7.4.1.4.3 Mexico
  • 7.4.2 Europe
    • 7.4.2.1 Europe Interventional Cardiology Devices Market, by Type
    • 7.4.2.2 Europe Interventional Cardiology Devices Market, by Application
    • 7.4.2.3 Europe Interventional Cardiology Devices Market, by End-user
    • 7.4.2.4 Europe Interventional Cardiology Devices Market, by Country
    • 7.4.2.4.1 France
    • 7.4.2.4.2 Germany
    • 7.4.2.4.3 United Kingdom
    • 7.4.2.4.4 Italy
    • 7.4.2.4.5 Spain
    • 7.4.2.4.6 Russia
    • 7.4.2.4.7 Rest of Europe
  • 7.4.3 Asia-Pacific
    • 7.4.3.1 Asia-Pacific Interventional Cardiology Devices Market, by Type
    • 7.4.3.2 Asia-Pacific Interventional Cardiology Devices Market, by Application
    • 7.4.3.3 Asia-Pacific Interventional Cardiology Devices Market, by End-user
    • 7.4.3.4 Asia-Pacific Interventional Cardiology Devices Market, by Country
    • 7.4.3.4.1 China
    • 7.4.3.4.2 Japan
    • 7.4.3.4.3 India
    • 7.4.3.4.4 Australia
    • 7.4.3.4.5 South Korea
    • 7.4.3.4.6 Rest of Asia Pacific
  • 7.4.4 Rest of the World (RoW)
    • 7.4.4.1 RoW Interventional Cardiology Devices Market, by Type
    • 7.4.4.2 RoW Interventional Cardiology Devices Market, by Application
    • 7.4.4.3 RoW Interventional Cardiology Devices Market, by End-user
    • 7.4.4.4 RoW Interventional Cardiology Devices Market, by Region
    • 7.4.4.4.1 Middle East
    • 7.4.4.4.2 Africa
    • 7.4.4.4.3 South America

8. Vascular Imaging Devices Global Company Share Analysis - Key 3-5 Companies

9. Vascular Imaging Devices Company and Product Profiles

• 9.1 Siemens Healthcare Limited
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4 Product Listing
  • 9.1.5. Entropy
• 9.2 General Electric Company (GE Healthcare)
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4 Product Listing
  • 9.2.5. Entropy
• 9.3 Koninklijke Philips N.V.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4 Product Listing
  • 9.3.5. Entropy
• 9.4 FUJIFILM Healthcare
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4 Product Listing
  • 9.4.5. Entropy
• 9.5 Samsung Medison Co., Ltd.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4 Product Listing
  • 9.5.5. Entropy
• 9.6 Shimadzu Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4 Product Listing
  • 9.6.5. Entropy
• 9.7 Hologic, Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4 Product Listing
  • 9.7.5. Entropy
• 9.8 Abbott Laboratories
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4 Product Listing
  • 9.8.5. Entropy
• 9.9 Carestream Health Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4 Product Listing
  • 9.9.5. Entropy
• 9.10 Toshiba Medical Systems Corporation
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4 Product Listing
  • 9.10.5. Entropy
• 9.11 Terumo Corporation
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4 Product Listing
  • 9.11.5. Entropy
• 9.12 ESAOTE SPA
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4 Product Listing
  • 9.12.5. Entropy
• 9.13 Konica Minolta, Inc.
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4 Product Listing
  • 9.13.5. Entropy
• 9.14 Alpinion Medical Systems Co., Ltd.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4 Product Listing
  • 9.14.5. Entropy
• 9.15 Pie Medical Imaging B.V
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4 Product Listing
  • 9.15.5. Entropy

10. PROJECT APPROACH

• 10.1 Secondary Sources
• 10.2 Primary Sources
• 10.3 Data Triangulation
• 10.4 Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight